(S)-3,3,3-Trifluoro-2-hydroxypropanoic acid, 97%, 250mg

Cyclopentane, min. 95%, for synthesis, 500 ml, glass packaging

Necrosulfonamide>95.0%(HPLC)25mg

2,2-BIS(BROMOMETHYL)-3-BROMOPROPANOIC ACID, 90.0%, 10g

3-Bromo-2,4-dimethoxypyridine, 97%, 5g

3-(P-tolyl)pyridine, 97%, 250mg

Ethyl 4-(4,4-dimethylpiperidin-1-yl)benzoate, 95.0%, 1g

2-CHLORO-4-(DIETHYLAMINO)PYRIDO[3,2-D]PYRIMIDINE, 97.0%, 1g

1-Methyl-4-(3-nitrophenyl)piperazine, 98%, 10g

3-Fluoro-5-nitrobenzaldehyde, 95.0%, 1g

Ethyl 2-Methyl-1,3-thiazole-5-carboxylate, 97.0%, 10g

Cover slips round sterile, , 22 mm 200 pcs

3,5-dibromo-1-(tetrahydro-2H-pyran-2-yl)-1H-1,2,4-triazole, 100mg